There are many stocks on the move for day traders and active traders this Wednesday morning now that earnings season has launched. Today’s top alerts are in BP plc (NYSE: BP), Cell Therapeutics, Inc. (NASDAQ: CTIC), Gentiva Health Services, Inc. (NASDAQ: GTIV), Intel Corporation (NASDAQ: INTC), Advanced Micro Devices Inc. (NYSE: AMD), ASML Holding N.V. (NASDAQ: ASML), NVIDIA Corporation (NASDAQ: NVDA), Semiconductor HOLDRs (NYSE: SMH), Jackson Hewitt Tax Service Inc. (NYSE: JTX), LHC Group, Inc. (NASDAQ: LHCG), and VIVUS, Inc. (NASDAQ: VVUS). We have given a synopsis on the news and added color for traders on each.
BP plc (NYSE: BP) is down about 1% this morning after it delayed well-cap tests at the Gulf of Mexico disaster until later Wednesday. This morning the oil flows freely.
Cell Therapeutics, Inc. (NASDAQ: CTIC) is trading up after it signed a long-term manufacturing agreement for its Pixantrone with NerPharMa. Shares are up 7%, but this is still a penny stock at $0.45.
Gentiva Health Services, Inc. (NASDAQ: GTIV) is down almost 13% at $19.42 on about 20,000 shares after an investigation on whether its practices led to overcharging Medicare.
Intel Corporation (NASDAQ: INTC) is stong and is actually up more than most indications last night after beating earnings handily and raising guidance. Shares are up about 6.5% at $22.38 on over 1 million shares in the first few minutes of the after-hours session. COATTAIL RIDERS:
- Advanced Micro Devices Inc. (NYSE: AMD) up almost 4% at $7.82;
- ASML Holding N.V. (NASDAQ: ASML) up 4.5% at $32.70;
- NVIDIA Corporation (NASDAQ: NVDA) up 4.4% at $11.40;
- Semiconductor HOLDRs (NYSE: SMH) indicated up almost 3% at $29.05.
Jackson Hewitt Tax Service Inc. (NYSE: JTX) is surging by 28%, but is still a very low-priced stock with shares at $1.67 after a close of $1.31. While sales were down, its cost cuts helped it to beat earnings expectations.
LHC Group, Inc. (NASDAQ: LHCG) is down 12.5% at $20.15 after an investigation on whether its practices led to overcharging Medicare.
VIVUS, Inc. (NASDAQ: VVUS) is trading higher again, but by a marginal amount. The FDA panel review for Qnexa in weight-loss begins today and the options activity and stock activity is expected to remain elevated.
JON C. OGG
Top Gaining Stocks
Top Losing Stocks